More than ever, the quality functions in biopharma manufacturing are under pressure. And that pressure is unlikely to be relieved any time soon due to an unprecedented level of regulatory and political scrutiny combined with a global market rife with a multitude of complex quality standards. It’s a scenario that has quality professionals struggling to embrace new and more efficient ways of manufacturing while maintaining compliance.
During the past decade there have been innumerable comparisons between stainless steel and single-use (SU) biomanufacturing systems. Anyone who has delved even slightly deep into the subject knows there isn’t a simple, clear cut answer to which system is “best.” The reality is that stainless steel and SU can coexist — and often do in today’s hybrid bioprocessing manufacturing environments.
A “CMO Leadership Awards” winner in all six categories for three consecutive years, Samsung Biologics provides cell-line development, commercial manufacturing of drug substance and drug product, along with biosafety testing and QC services, all from a single location. Learn more.